XML 40 R29.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Revenue Recognition - Disaggregated Sales Analysis (Details) - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended
--- | --- | ---
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | $ 4,479 | $ 4,160 | $ 13,247 | $ 12,407
United States |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 3,360 | 3,019 | 9,776 | 8,903
International |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 1,119 | 1,141 | 3,471 | 3,504
MedSurg and Neurotechnology: |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 2,588 | 2,349 | 7,560 | 6,899
MedSurg and Neurotechnology: | United States |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 1,985 | 1,754 | 5,713 | 5,070
MedSurg and Neurotechnology: | International |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 603 | 595 | 1,847 | 1,829
MedSurg and Neurotechnology: | Instruments |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 535 | 525 | 1,626 | 1,511
MedSurg and Neurotechnology: | Instruments | United States |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 425 | 415 | 1,290 | 1,171
MedSurg and Neurotechnology: | Instruments | International |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 110 | 110 | 336 | 340
MedSurg and Neurotechnology: | Endoscopy |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 590 | 525 | 1,728 | 1,512
MedSurg and Neurotechnology: | Endoscopy | United States |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 480 | 418 | 1,371 | 1,179
MedSurg and Neurotechnology: | Endoscopy | International |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 110 | 107 | 357 | 333
MedSurg and Neurotechnology: | Medical |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 765 | 636 | 2,095 | 1,898
MedSurg and Neurotechnology: | Medical | United States |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 625 | 496 | 1,686 | 1,457
MedSurg and Neurotechnology: | Medical | International |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 140 | 140 | 409 | 441
MedSurg and Neurotechnology: | Neurovascular |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 294 | 295 | 901 | 885
MedSurg and Neurotechnology: | Neurovascular | United States |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 110 | 113 | 333 | 339
MedSurg and Neurotechnology: | Neurovascular | International |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 184 | 182 | 568 | 546
MedSurg and Neurotechnology: | Neuro Cranial |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 332 | 299 | 992 | 890
MedSurg and Neurotechnology: | Neuro Cranial | United States |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 274 | 244 | 819 | 724
MedSurg and Neurotechnology: | Neuro Cranial | International |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 58 | 55 | 173 | 166
MedSurg and Neurotechnology: | Other |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 72 | 69 | 218 | 203
MedSurg and Neurotechnology: | Other | United States |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 71 | 68 | 214 | 200
MedSurg and Neurotechnology: | Other | International |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 1 | 1 | 4 | 3
Orthopaedics and Spine: |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 1,891 | 1,811 | 5,687 | 5,508
Orthopaedics and Spine: | United States |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 1,375 | 1,265 | 4,063 | 3,833
Orthopaedics and Spine: | International |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 516 | 546 | 1,624 | 1,675
Orthopaedics and Spine: | Other |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 111 | 123 | 322 | 373
Orthopaedics and Spine: | Other | United States |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 85 | 97 | 243 | 290
Orthopaedics and Spine: | Other | International |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 26 | 26 | 79 | 83
Orthopaedics and Spine: | Knees |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 481 | 439 | 1,445 | 1,325
Orthopaedics and Spine: | Knees | United States |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 365 | 321 | 1,078 | 964
Orthopaedics and Spine: | Knees | International |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 116 | 118 | 367 | 361
Orthopaedics and Spine: | Hips |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 347 | 328 | 1,038 | 990
Orthopaedics and Spine: | Hips | United States |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 225 | 199 | 657 | 606
Orthopaedics and Spine: | Hips | International |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 122 | 129 | 381 | 384
Orthopaedics and Spine: | Trauma and Extremities |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 672 | 639 | 2,033 | 1,953
Orthopaedics and Spine: | Trauma and Extremities | United States |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 494 | 447 | 1,470 | 1,362
Orthopaedics and Spine: | Trauma and Extremities | International |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 178 | 192 | 563 | 591
Orthopaedics and Spine: | Spine |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 280 | 282 | 849 | 867
Orthopaedics and Spine: | Spine | United States |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 206 | 201 | 615 | 611
Orthopaedics and Spine: | Spine | International |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | $ 74 | $ 81 | $ 234 | $ 256

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_DisaggregationOfRevenueLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 28 -Subparagraph (f) -URI http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iv)) -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iv)) -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(A)) -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(i)) -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(i)) -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(5)) -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iii)(A)) -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756 Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(5)) -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690 Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 235 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-05(b)(2)) -URI http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884 Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(B)) -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756 Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(ii)) -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756 Reference 23: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(1)) -URI http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227 + Details
Name: | us-gaap_Revenues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | srt_StatementGeographicalAxis=country_US
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=us-gaap_NonUsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=syk_InstrumentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=syk_EndoscopyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=syk_MedicalMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=syk_NeurovascularMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=syk_NeuroCranialMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=syk_OtherOrthopaedicsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=syk_KneesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=syk_HipsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=syk_TraumaandExtremitiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=syk_SpineMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |